Simpler Grants.gov #FOR-FD-24-012

FDA Seeks Management of Critical Path Institute Consortia Groups Under Cooperative Agreement

The Food and Drug Administration (FDA) is inviting applications for a cooperative agreement to manage and maintain consortia groups established by the Critical Path Institute under the Critical Path Initiative. - Government Buyer: - Food and Drug Administration (FDA) - OEMs and Vendors: - Critical Path Institute (only named organization responsible for the consortia groups) - Products/Services Requested: - Ongoing management and support of existing consortia groups - Activities include collaborative projects in research, education, and outreach to foster drug product innovation - No specific products, part numbers, or quantities are requested - Unique or Notable Requirements: - Opportunity is a renewal of a previous cooperative agreement (#5U18FD005320) - Focus on accelerating development, manufacturing, and translational therapeutics - Emphasis on enhancing safety, efficacy, quality, and performance in drug development - Estimated award amount is $20,000,000 with one expected recipient - No cost sharing or matching required; funding instrument is a cooperative agreement or grant

Description

The FDA seeks applications to continue maintaining and managing existing consortia groups established by the Critical Path Institute. This renewal cooperative agreement supports the Critical Path Initiative to foster drug product innovation through collaborative projects in research, education, and outreach. The initiative aims to accelerate development, manufacturing, and translational therapeutics while enhancing safety, efficacy, quality, and performance. Funding is subject to availability of FDA funds.

View original listing